Executives On The Move: Kite Pharma Announces Its Next CEO And A Trio Of VPs For Tilray
Executive Summary
T-cell therapy firm Kite Pharma announces a former Eli Lilly VP as its next CEO. Over at Canadian pharma and cannabis business Tilray, three new VPs for Europe in expansion, marketing and commercial development.